- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 948564-73-6] Fresolimumab
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-P99020 |
| Brand: | MCE |
| CAS: | 948564-73-6 |
Overview
| MDL | - |
|---|---|
| Molecular Weight | - |
| Molecular Formula | Unspecified |
| SMILES | [Fresolimumab] |
Summary
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT00356460 | Genzyme, a Sanofi Company|Sanofi |
Carcinoma, Renal Cell|Melanoma
|
September 2006 | Phase 1 |
| NCT03064074 | Baylor College of Medicine|Genzyme, a Sanofi Company|Oregon Health and Science University |
Osteogenesis Imperfecta
|
November 15, 2017 | Phase 1 |
| NCT01401062 | Weill Medical College of Cornell University|University of California, Los Angeles |
Metastatic Breast Cancer
|
July 2011 | Phase 2 |
| NCT01284322 | Boston University |
Diffuse Systemic Sclerosis
|
January 2011 | Phase 1 |
| NCT00464321 | Genzyme, a Sanofi Company|Sanofi |
Focal Segmental Glomerulosclerosis
|
May 2007 | Phase 1 |
| NCT01665391 | Genzyme, a Sanofi Company|Sanofi |
Primary Focal Segmental Glomerulosclerosis
|
August 2012 | Phase 2 |
| NCT01472731 | University Medical Center Groningen|Genzyme, a Sanofi Company |
Primary Brain Tumors
|
December 2011 | Phase 2 |
| NCT01112293 | Abramson Cancer Center of the University of Pennsylvania |
Pleural Malignant Mesothelioma
|
April 2010 | Phase 2 |
| NCT02581787 | Maximilian Diehn|Varian|Stanford University |
Stage IA Non-Small Cell Lung Carcinoma|Stage IB Non-Small Cell Lung Carcinoma
|
August 2016 | Phase 1|Phase 2 |
| NCT00125385 | Genzyme, a Sanofi Company|Sanofi |
Idiopathic Pulmonary Fibrosis
|
July 2005 | Phase 1 |
Appearance
Liquid
Shipping
Shipping with dry ice.
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Synonyms
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.